. 2012 Jul;5(4):423–433. doi: 10.1242/dmm.009092
© 2012. Published by The Company of Biologists Ltd
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Share Alike License (http://creativecommons.org/licenses/by-nc-sa/3.0), which permits unrestricted non-commercial use, distribution and reproduction in any medium provided that the original work is properly cited and all further distributions of the work or adaptation are subject to the same Creative Commons License terms
Table 1.
Efficacy of FDA-approved biologic drugs for psoriasis at 10–16 weeks
